WormBase Tree Display for Variation: WBVar00145032
expand all nodes | collapse all nodes | view schema
WBVar00145032 | Evidence | Paper_evidence | WBPaper00031667 | |||||
---|---|---|---|---|---|---|---|---|
Name | Public_name | e2883 | ||||||
Other_name | CE54583:p.Gly392Glu | |||||||
CE28488:p.Gly378Glu | ||||||||
T23F2.1b.1:c.1175G>A | ||||||||
T23F2.1a.1:c.1133G>A | ||||||||
HGVSg | CHROMOSOME_X:g.5495366G>A | |||||||
Sequence_details | SMap | S_parent | Sequence | T23F2 | ||||
Flanking_sequences | atcgccttgaaaccgaattctccacgcgcg | attttgtgggaatatcgaccgagccattgc | ||||||
Mapping_target | T23F2 | |||||||
Type_of_mutation | Substitution | g | a | Paper_evidence | WBPaper00031667 | |||
SeqStatus | Sequenced | |||||||
Variation_type | Allele | |||||||
Origin | Species | Caenorhabditis elegans | ||||||
Strain | WBStrain00004683 | |||||||
WBStrain00004745 | ||||||||
Laboratory | CB | |||||||
Status | Live | |||||||
Affects | Gene | WBGene00044623 | ||||||
Transcript | T23F2.1b.1 | VEP_consequence | missense_variant | |||||
VEP_impact | MODERATE | |||||||
HGVSc | T23F2.1b.1:c.1175G>A | |||||||
HGVSp | CE54583:p.Gly392Glu | |||||||
cDNA_position | 1175 | |||||||
CDS_position | 1175 | |||||||
Protein_position | 392 | |||||||
Exon_number | 9/9 | |||||||
Codon_change | gGa/gAa | |||||||
Amino_acid_change | G/E | |||||||
T23F2.1a.1 (12) | ||||||||
Genetics | Interpolated_map_position | X | -5.23905 | |||||
Description | Phenotype | WBPhenotype:0000010 | Paper_evidence | WBPaper00031667 | ||||
Curator_confirmed | WBPerson712 | |||||||
Remark | Animals show weak but significant enhanced sensitivity to drugs of a variety of sizes and structures. | Paper_evidence | WBPaper00031667 | |||||
Curator_confirmed | WBPerson712 | |||||||
Phenotype_assay | Treatment | Gravid hermaphrodites were placed into wells (of 96-well plates) containing the compound. Sensitivity was assessed based on the time until paralysis ensued. Concentrations of the compounds are as follows: Nicotine, 0.1%v/v in M9; 1-Phenoxypropan-2-ol , 0.1% or 0.5% in M9; Ivermectin dissolved in DMSO and diluted to 2.5ug/ml in M9. | Paper_evidence | WBPaper00031667 | ||||
Curator_confirmed | WBPerson712 | |||||||
WBPhenotype:0000054 | Paper_evidence | WBPaper00031667 | ||||||
Curator_confirmed | WBPerson712 | |||||||
Remark | Animals show weak larval lethality. | Paper_evidence | WBPaper00031667 | |||||
Curator_confirmed | WBPerson712 | |||||||
Phenotype_assay | Temperature | 22.5 | Paper_evidence | WBPaper00031667 | ||||
Curator_confirmed | WBPerson712 | |||||||
WBPhenotype:0001209 | Paper_evidence | WBPaper00031667 | ||||||
Curator_confirmed | WBPerson712 | |||||||
Remark | Animals are weakly Unc. | Paper_evidence | WBPaper00031667 | |||||
Curator_confirmed | WBPerson712 | |||||||
WBPhenotype:0001413 | Paper_evidence | WBPaper00031667 | ||||||
Curator_confirmed | WBPerson712 | |||||||
WBPhenotype:0001918 | Paper_evidence | WBPaper00052991 | ||||||
Curator_confirmed | WBPerson38714 | |||||||
Phenotype_not_observed | WBPhenotype:0000050 | Paper_evidence | WBPaper00031667 | |||||
Curator_confirmed | WBPerson712 | |||||||
Reference | WBPaper00031667 | |||||||
WBPaper00052991 | ||||||||
Method | Substitution_allele |